Wang, Z., Li, B., Li, S., Lin, W., Wang, Z., Wang, S., Chen, W., Shi, W., Chen, T., Zhou, H., Yinwang, E., Zhang, W., Mou, H., Chai, X., Zhang, J., Lu, Z., & Ye, Z
Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, Ramirez-Acua JM, Perez-Romero BA, Guerrero-Rodriguez JF, et al
Until rigorous, randomized, placebo-controlled trials are conducted and published, the responsible position is to rely on proven, evidence-based approaches to recovery and healing, and to leave unapproved peptides where they belong for now: in the laboratory, not in your body.
NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42)
Reasons to Review Safety and Quality Standards: Make sure the products are safe and effective
New perspectives provided by proteomics Discovery of protein markers In depression research, the application of proteomics allows for the identification of potential biomarkers, which are crucial for the early diagnosis and personalized treatment of the disorder